Awan FT, Yande S, Esterberg L, Nagar SP, Goyal RK, Priyadarshini M. Economic burden in patients (pt) with CLL/SLL (CLL) who received ≥ 2 prior lines of therapy (LOT), including a Bruton tyrosine kinase inhibitor (BTKi): a SEER-Medicare analysis. Poster presented at the ASCO Quality Care Symposium 2023; October 27, 2023. Boston, MA. [abstract] JCO Oncol Pract. 2023 Nov 1; 19(11 Suppl):23-4. doi: 10.1200/OP.2023.19.11_suppl.24
Gnanasakthy A, Norcross L, Clark M, Fitzgerald K. A review of patient-reported outcome considerations in oncologic drug advisory committee meetings (2016-2021). JCO Oncol Pract. 2023 May;19(5):e745-62. doi: 10.1200/OP.22.00774
Dattilo J, Siperstein GN, McDowell ED, Schleien SJ, Whitaker E, Block M, Spolidoro M, Bari J, Hall A. Perceptions of programming needs for inclusive leisure services. JPRA. 2019 Oct 24;37(4):70-91. doi: 10.18666/JPRA-2019-9514
Brown JP, Amaechi BT, Bader JD, Shugars D, Vollmer WM, Chen C, Gilbert GH, Esterberg EJ, X-ACT Collaborative Research Group. The dynamic behavior of the early dental caries lesion in caries-active adults and implications. Community Dent Oral Epidemiol. 2015 Jun;43(3):208-16. doi: 10.1111/cdoe.12143